Ryoji Nishimura

Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism

Kazuhide Hayakawa, Kenichi Mishima, Mai Hazekawa et al. · Brain Research · 2007 · 138 citations

Medicine, Neuroscience, Pharmacology +9

Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex

Nobuaki Egashira, Katsunori Iwasaki, Ayumi Ishibashi et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2008 · 106 citations

Life Sciences, Neuroscience, Pharmacology +13

Effects of glutamate-related drugs on marble-burying behavior in mice: Implications for obsessive–compulsive disorder

Nobuaki Egashira, Ryoko Okuno, Satoko Harada et al. · European Journal of Pharmacology · 2008 · 95 citations

Medicine, Neuroscience, Pharmacology +16

Antipsychotics improve Δ9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice

Hiroshi Nagai, Nobuaki Egashira, Kazunori Sano et al. · Pharmacology Biochemistry and Behavior · 2006 · 73 citations

Medicine, Neuroscience, Pharmacology +15

Efficacy and safety of aripiprazole once-monthly in Asian patients with schizophrenia: A multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazole

Jun Ishigooka, Jun Nakamura, Yasuo Fujii et al. · Schizophrenia Research · 2014 · 70 citations

Medicine, Pharmacology, Pharmacotherapy +16